Neonc Technologies Holdings (NTHI) Common Equity (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Common Equity of -$13.2 million for Q1 2026, down 37.49% year-over-year from -$21.2 million in Q1 2025, and up 24.43% quarter-over-quarter from -$17.5 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Common Equity (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Common Equity for 3 consecutive years, with -$13.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 37.49% year-over-year to -$13.2 million; the TTM figure through Mar 2026 stood at -$13.2 million (down 37.49% YoY), while the FY2025 annual figure was -$17.5 million, down 218.04% from the prior year.
- Common Equity climbed to -$13.2 million in Q1 2026 per NTHI's latest filing, from -$17.5 million in the prior quarter.
- Across five years, Common Equity topped out at -$5.3 million in Q3 2024 and bottomed at -$17.5 million in Q4 2025.
- Historically, Common Equity has averaged -$10.9 million across 3 years, with a median of -$11.8 million in 2025.
- On a YoY basis, Common Equity climbed as much as 43.15% in 2025 and fell as far as 218.04% in 2025.
- Neonc Technologies Holdings' Common Equity stood at -$5.5 million in 2024, then plunged by 218.04% to -$17.5 million in 2025, then rose by 24.43% to -$13.2 million in 2026.
- Business Quant data shows NTHI's Common Equity at -$13.2 million in Q1 2026, -$17.5 million in Q4 2025, and -$11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -18.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.53 Mn |
| Mar 31, 2026 | -13.23 Mn |
| Dec 31, 2025 | -17.51 Mn |
| Sep 30, 2025 | -11.81 Mn |
| Jun 30, 2025 | -11.82 Mn |
| Mar 31, 2025 | -9.62 Mn |
| Dec 31, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.27 Mn |
| Jun 30, 2024 | -6.21 Mn |
| Mar 31, 2024 | -16.93 Mn |